Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
In the latest session, Vera Therapeutics Inc (NASDAQ: VERA) closed at $33.70 up 0.99% from its previous closing price of $33.37. In other words, the price has increased by $0.99 from its previous closing price. On the day, 0.98 million shares were traded. VERA stock price reached its highest trading level at $34.35 during the session, while it also had its lowest trading level at $33.34.
Ratios:
For a deeper understanding of Vera Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 13.60 and its Current Ratio is at 13.60. In the meantime, Its Debt-to-Equity ratio is 0.19 whereas as Long-Term Debt/Eq ratio is at 0.18.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on November 21, 2024, initiated with a Overweight rating and assigned the stock a target price of $70.
On January 25, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $26.Oppenheimer initiated its Outperform rating on January 25, 2024, with a $26 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 08 ’25 when Fordyce Marshall sold 17,500 shares for $41.74 per share. The transaction valued at 730,535 led to the insider holds 143,603 shares of the business.
MARSHALL FORDYCE bought 17,500 shares of VERA for $736,750 on Jan 08 ’25. On Dec 18 ’24, another insider, Fordyce Marshall, who serves as the PRESIDENT AND CEO of the company, sold 17,500 shares for $43.07 each. As a result, the insider received 753,680 and left with 85,942 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VERA now has a Market Capitalization of 2133988480 and an Enterprise Value of 1835587840.
Stock Price History:
The Beta on a monthly basis for VERA is 1.12, which has changed by 0.9606346 over the last 52 weeks, in comparison to a change of 0.23171377 over the same period for the S&P500. Over the past 52 weeks, VERA has reached a high of $51.61, while it has fallen to a 52-week low of $14.20. The 50-Day Moving Average of the stock is -23.60%, while the 200-Day Moving Average is calculated to be -16.69%.
Shares Statistics:
For the past three months, VERA has traded an average of 779.42K shares per day and 766650 over the past ten days. A total of 55.03M shares are outstanding, with a floating share count of 48.99M. Insiders hold about 22.63% of the company’s shares, while institutions hold 77.57% stake in the company. Shares short for VERA as of 1735603200 were 7153678 with a Short Ratio of 9.18, compared to 1732838400 on 6519748. Therefore, it implies a Short% of Shares Outstanding of 7153678 and a Short% of Float of 15.07.
